Caitong International Asset Management Co., Ltd
Position in TXG — 10x Genomics, Inc.
CIK 1963355
HONG KONG, K3
Position in TXG
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$306,566
+$292,165 QoQ
Shares Held
7,996
+805.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#264
of 393 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Caitong International Asset Management Co., Ltd holds $2,332,345 across 75 Medical Devices names. TXG ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
10,214 | $435,933 | |
| 2 | ATEC |
Alphatec Holdings, Inc.
|
45,692 | $395,235 | |
| 3 | TXG |
10x Genomics, Inc.
This page
|
7,996 | $306,566 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
19,968 | $301,317 | |
| 5 | SNN |
Smith & Nephew PLC
|
6,056 | $174,473 | |
| 6 | PHG |
Koninklijke Philips NV
|
5,820 | $158,245 | |
| 7 | DXCM |
Dexcom Inc
|
1,485 | $100,014 | |
| 8 | PACB |
Pacific Biosciences Of California, Inc.
|
41,895 | $70,383 |
All Filings in TXG
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,566 | 7,996 | Shares | Sole | 2026-08-05 | |
| 2025-12-31 | $14,401 | 883 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $15,968 | 1,366 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $3,937 | 340 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $43 | 5 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,714 | 189 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||